New diabetes clinical trial: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Published on: September 28, 2025 at 11:00PM
Conditions: Prediabetes / Type 2 Diabetes
Interventions: Dietary Supplement: AMPK Charge+®; Dietary Supplement: AMPK Charge+® with semaglutide
Sponsors: QuickSilver Scientific; KGK Science Inc.
Not yet recruiting
https://ift.tt/PsqiQLT